Bluepal Labs Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 13.00 Cr
as on 16-11-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.59 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit 37.20%
(FY 2023)
- Net Worth -15.70%
(FY 2023)
- Total Assets 266.02%
(FY 2023)
About Bluepal Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 13.00 Cr.
The company currently has active open charges totaling ₹25.59 Cr.
Anantha Mantena, Saikrishnam Manthena, Siva Manthena, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290TG2020PTC140484
- Company No.
140484
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bluepal Labs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manthena Srinivasa  | Director | 28-May-2020 | Current |
| Anantha Mantena | Director | 28-May-2020 | Current |
| Saikrishnam Manthena | Director | 09-Nov-2020 | Current |
| Siva Manthena | Director | 09-Nov-2020 | Current |
Financial Performance of Bluepal Labs.
Bluepal Labs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 37.2% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bluepal Labs?
Unlock access to Bluepal Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Surya Vamsi Shrimp Hatcheries Private LimitedActive 30 years 2 monthsAnantha Mantena is a mutual person
- Blue Pal Solutions Private LimitedActive 20 years 2 months
Anantha Mantena and Manthena Srinivasa are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 14 Dec 2023 | ₹25.59 Cr | Open |
How Many Employees Work at Bluepal Labs?
Unlock and access historical data on people associated with Bluepal Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bluepal Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bluepal Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
